A recent survey,“Pharmaceutical Product Forecasting and Its Impact on Manufacturing,” conducted by ORC International and sponsored by Patheon, found a majority of companies had either overestimated or underestimated demand for new drugs by as much as 25%, with some reporting instances off by more than 50%. The white paper includes insights from 50 pharma industry senior managers and includes commentary from Jim Miller, founder and president of PharmSource.   Failing to meet forecasted demand w...